Name: Benitec Biopharma Inc. (BNTC) Balance Sheet
Creator: FinSpry

Benitec Biopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Benitec Biopharma Inc. (BNTC) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Current Assets
Cash and Cash Equivalents	97.74	50.87	2.48	4.06	19.77	9.80
Cash & Short-Term Investments	97.74	50.87	2.48	4.06	19.77	9.80
Accounts Receivable	0.03	0.23	0.06	0.00	0.03	0.06
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.74	0.52	1.18	0.74	0.98	0.95
Total Current Assets	98.52	51.67	3.73	4.82	20.61	10.81
Non-Current Assets
Property, Plant & Equipment (Net)	0.99	0.45	0.61	0.99	0.58	0.77
Other Non-Current Assets	0.08	0.09	0.12	0.16	0.19	0.00
Total Non-Current Assets	1.07	51.38	0.74	1.15	0.76	0.77
Total Assets	99.59	52.21	4.46	5.97	21.38	11.59
Current Liabilities
Accounts Payable	1.02	1.35	1.14	0.42	0.88	0.74
Short-Term Debt	0.35	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	0.75	0.65	0.74	0.70	0.49	0.00
Other Current Liabilities	0.43	2.64	1.82	1.16	0.28	0.20
Total Current Liabilities	1.80	4.92	3.98	2.53	1.37	1.14
Non-Current Liabilities
Long-Term Debt	0.50	0.00	0.28	0.56	0.00	0.21
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.50	0.04	0.28	0.56	0.00	0.21
Total Liabilities	2.30	4.96	4.26	3.09	1.37	1.35
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-228.18	-190.26	-167.89	-148.33	-131.57	-118.59
Accumulated Other Comprehensive Income	-0.84	-0.89	-0.83	-1.25	-1.46	0.00
Additional Paid-in Capital	326.31	238.40	168.92	152.45	151.58	128.83
Shares Outstanding	26.25	10.09	1.65	0.48	0.00	0.00
Total Stockholders' Equity	97.30	47.25	0.20	2.88	20.01	10.24
Total Liabilities & Equity	99.59	52.21	4.46	5.97	21.38	11.59